Robert A Harrington Selected Research

Robert A Harrington Research Topics

Disease

174	Acute Coronary Syndrome 10/2023 - 07/2001
171	Myocardial Infarction 04/2024 - 07/2001
127	Hemorrhage 04/2024 - 01/2002
60	Thrombosis (Thrombus) 03/2024 - 05/2002
58	Stroke (Strokes) 04/2024 - 12/2002
47	Ischemia 04/2024 - 02/2002
28	Unstable Angina 01/2022 - 07/2001
27	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 06/2002
26	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 01/2002
26	ST Elevation Myocardial Infarction 06/2022 - 04/2003
21	Coronary Disease (Coronary Heart Disease) 04/2024 - 05/2002
19	Heart Failure 01/2018 - 01/2003
15	Venous Thromboembolism 02/2023 - 09/2004
15	Infarction (Infarctions) 11/2013 - 06/2002
13	Diabetes Mellitus 04/2024 - 06/2005
10	Ischemic Stroke 04/2024 - 09/2004
9	Chronic Renal Insufficiency 04/2024 - 03/2008
9	Atrial Fibrillation 03/2023 - 09/2004
7	Venous Thrombosis (Deep-Vein Thrombosis) 12/2018 - 03/2017
6	Type 2 Diabetes Mellitus (MODY) 04/2024 - 05/2019
6	Pathologic Constriction (Stenosis) 01/2023 - 11/2008
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 04/2003
5	Hypersensitivity (Allergy) 04/2024 - 09/2004
5	Vascular Diseases (Vascular Disease) 11/2022 - 07/2003
5	Renal Insufficiency (Renal Failure) 01/2019 - 09/2006
5	Stable Angina 11/2018 - 05/2012
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 10/2004
5	Pulmonary Embolism 01/2018 - 03/2017
4	Hypertension (High Blood Pressure) 09/2022 - 09/2006
4	Inflammation (Inflammations) 06/2022 - 04/2007
4	Necrosis 06/2022 - 03/2008
4	Non-ST Elevated Myocardial Infarction 02/2022 - 04/2007
4	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2014
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2013 - 07/2003
4	Reperfusion Injury 11/2013 - 11/2005
4	Cardiogenic Shock 12/2012 - 04/2007

Drug/Important Bio-Agent (IBA)

66	Clopidogrel (Plavix)FDA Link 11/2022 - 09/2004
40	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 06/2002
38	TicagrelorIBA 04/2024 - 11/2007
34	Eptifibatide (Integrilin)FDA Link 04/2017 - 07/2001
33	cangrelorIBA 03/2022 - 03/2006
33	Glycoproteins (Glycoprotein)IBA 01/2018 - 01/2002
21	vorapaxarIBA 11/2022 - 03/2009
20	Thrombin Receptors (Thrombin Receptor)IBA 11/2022 - 01/2012
19	alirocumabIBA 04/2024 - 11/2014
19	Enoxaparin (Lovenox)FDA LinkGeneric 02/2023 - 10/2003
17	Platelet Membrane GlycoproteinsIBA 02/2008 - 07/2001
16	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2023 - 07/2004
16	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2004
15	AnticoagulantsIBA 03/2023 - 05/2002
15	Heparin (Liquaemin)FDA LinkGeneric 03/2019 - 08/2002
15	Platelet Membrane Glycoprotein IIbIBA 01/2018 - 12/2002
13	omega-Chloroacetophenone (Mace)IBA 04/2024 - 11/2012
13	betrixabanIBA 02/2023 - 11/2016
11	paragonIBA 12/2010 - 02/2002
10	LDL CholesterolIBA 03/2023 - 11/2008
10	CreatinineIBA 08/2016 - 07/2003
9	apixabanIBA 01/2020 - 06/2009
9	Streptokinase FDA Link 09/2019 - 07/2002
9	bivalirudin (Angiomax)FDA Link 01/2017 - 02/2003
9	MB Form Creatine KinaseIBA 11/2009 - 09/2003
8	fibrin fragment D (D-dimer)IBA 02/2023 - 03/2017
8	AntithrombinsIBA 09/2010 - 02/2003
8	Tenecteplase FDA Link 03/2005 - 04/2003
7	oxidized low density lipoproteinIBA 12/2020 - 11/2008
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 09/2004
7	EnzymesIBA 05/2014 - 02/2002
6	CholesterolIBA 04/2024 - 11/2007
6	C-Reactive ProteinIBA 09/2022 - 04/2010
6	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 01/2014
6	TroponinIBA 02/2022 - 01/2006
6	Proprotein Convertase 9IBA 01/2022 - 11/2018
6	Purinergic P2Y Receptor AntagonistsIBA 12/2018 - 11/2007
6	Factor Xa InhibitorsIBA 01/2017 - 05/2002
5	Growth Differentiation Factor 15IBA 11/2022 - 01/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2010
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2015 - 07/2003
5	Abciximab (ReoPro)FDA Link 03/2006 - 09/2002
4	HDL LipoproteinsIBA 04/2024 - 08/2014
4	CSL112IBA 04/2024 - 10/2016
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 10/2016
4	Lipoprotein(a)IBA 10/2023 - 01/2020
4	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2022 - 10/2017
4	Lipoproteins (Lipoprotein)IBA 09/2022 - 01/2019
4	Peptide Hydrolases (Proteases)FDA Link 12/2018 - 03/2014
4	CalciumIBA 12/2016 - 01/2007
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2015 - 09/2004
4	MetalsIBA 09/2014 - 01/2007
4	Creatine Kinase (Creatine Phosphokinase)IBA 11/2009 - 01/2006

Therapy/Procedure

123	Therapeutics 04/2024 - 07/2001
81	Percutaneous Coronary Intervention 01/2023 - 06/2002
46	Stents 03/2024 - 02/2003
39	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 01/2002
12	Blood Transfusion (Blood Transfusions) 10/2023 - 07/2004
11	Patient Readmission 01/2018 - 07/2008
10	Secondary Prevention 02/2024 - 08/2003
10	Thrombolytic Therapy 02/2022 - 01/2003
7	Drug-Eluting Stents 03/2019 - 06/2003
4	Conservative Treatment 04/2024 - 01/2018
4	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2017 - 04/2008